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Summary
Our aim was to prospectively determine the predictive capabilities of SEPSIS-1 and SEPSIS-3 deﬁnitions in the emer-
gency departments and general wards. Patients with National Early Warning Score (NEWS) of 3 or above and sus-
pected or proven infection were enrolled over a 24-h period in 13 Welsh hospitals. The primary outcome measure was
mortality within 30 days. Out of the 5422 patients screened, 431 fulﬁlled inclusion criteria and 380 (88%) were
recruited. Using the SEPSIS-1 deﬁnition, 212 patients had sepsis. When using the SEPSIS-3 deﬁnitions with Sequential
Organ Failure Assessment (SOFA) score ≥ 2, there were 272 septic patients, whereas with quickSOFA score ≥ 2, 50
patients were identiﬁed. For the prediction of primary outcome, SEPSIS-1 criteria had a sensitivity (95%CI) of 65%
(54–75%) and speciﬁcity of 47% (41–53%); SEPSIS-3 criteria had a sensitivity of 86% (76–92%) and speciﬁcity of 32%
(27–38%). SEPSIS-3 and SEPSIS-1 deﬁnitions were associated with a hazard ratio (95%CI) 2.7 (1.5–5.6) and 1.6 (1.3–
2.5), respectively. Scoring system discrimination evaluated by receiver operating characteristic curves was highest for
Sequential Organ Failure Assessment score (0.69 (95%CI 0.63–0.76)), followed by NEWS (0.58 (0.51–0.66))
(p < 0.001). Systemic inﬂammatory response syndrome criteria (0.55 (0.49–0.61)) and quickSOFA score (0.56 (0.49–
0.64)) could not predict outcome. The SEPSIS-3 deﬁnition identiﬁed patients with the highest risk. Sequential Organ
Failure Assessment score and NEWS were better predictors of poor outcome. The Sequential Organ Failure Assessment
score appeared to be the best tool for identifying patients with high risk of death and sepsis-induced organ dysfunction.
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Introduction
Sepsis is deﬁned as a dysregulated host response to
infection, resulting in acute organ dysfunction [1].
Although the condition has been thoroughly studied in
the intensive care unit (ICU), accurate data collection
outside of this setting is less well-developed. It is
thought, however, that the number of cases in the
wider hospital is far higher [2–4]. In the UK, anaes-
thetists and critical care practitioners have been at the
forefront of developing effective systems to identify
and treat patients with sepsis outside critical care
areas. They have identiﬁed a clear need to understand
the signiﬁcance of the condition in the pre-ICU envi-
ronment and the tools we might use to identify and
treat those most at risk [5].
We previously reported the results of a point-pre-
valence feasibility study and subsequent study of all
Welsh centres using the 1992 International Consensus
Criteria for sepsis (SEPSIS-1), using electronic data
collection and real-time data monitoring [6–8]. We
found that 4% of hospitalised patients had sepsis, half
of whom had signiﬁcant organ dysfunction (severe
sepsis). Strikingly, the 90-day mortality among the
whole hospital cohort was in excess of 30% for sepsis,
and almost 40% for severe sepsis [7].
Concurrently, the validity and clinical utility of the
existing sepsis deﬁnitions, which had previously been
based on the concept of the systemic inﬂammatory
response syndrome (SIRS), were questioned [9]. The
Third International Consensus Deﬁnitions for sepsis
(SEPSIS-3) have recently been published, with signiﬁ-
cantly revised clinical criteria, including the use of
Sequential Organ Failure Assessment (SOFA) scores
and the quick SOFA (qSOFA) screening tool for non-
ICU settings [1, 10]. During the development phase,
most of the datasets used were from North America,
and included variable proportions of non-ICU patients
[10]. It is not known how the new SEPSIS-3 deﬁnitions
would perform compared with SEPSIS-1 deﬁnitions in
identifying patients at risk with sepsis in a UK ward set-
ting, and furthermore how they might perform com-
pared with a well-established track and trigger tool, the
National Early Warning Score (NEWS) [11, 12].
Our objectives were to determine the ability of the
SEPSIS-1 deﬁnition using the SIRS criteria, the SEP-
SIS-3 deﬁnition using SOFA and qSOFA scores and
the NEWS track and trigger tool to predict outcome
outside of the ICU.
Methods
This multi-centre, prospective, observational study of
patients with suspected sepsis in 13 hospitals in Wales
was approved by the South Wales Regional Ethics
Committee, and patients or their proxy, in cases of
patients lacking capacity, gave written informed con-
sent. We enrolled consecutive patients presenting to
hospitals in Wales with 24/7 consultant-level emer-
gency department (ED) supervision, and the facility to
admit and treat any acutely unwell patient. We
screened patients in the ED or in an acute in-patient
ward setting with suspected or proven infection on 19
October 2016, Wednesday (08:00 h to 07:59 h the fol-
lowing day). This date represented a typically ‘average’
day in the national health service [13, 14]. We
approached all patients with NEWS ≥ 3 in whom the
treating clinical teams had a high degree of clinical
suspicion of an infection (documented as such in the
medical or nursing notes), and following consent, we
screened for the presence of sepsis using either SEP-
SIS-1 or SEPSIS-3 deﬁnitions.
We did not study patients if they were less than
18 years of age, or if they were already in intensive care
or high dependency units. We referred patients to the
clinical teams if the medical student data collectors felt
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they needed urgent medical attention due to their condi-
tion, in line with the requirements of the ethics approval.
To facilitate linkage to national databases for the collec-
tion of follow-up data, we collected patient-identiﬁable
data and entered it on to the secure data collection tool.
We deﬁned sepsis as the presence or strong suspi-
cion of infection, together with two or more SIRS crite-
ria according to the SEPSIS-1 deﬁnition; or as the
presence or strong suspicion of infection together with
SOFA score 2 or above, or qSOFA score 2 or above,
according to the SEPSIS-3 deﬁnition. We used the SIRS
criteria: respiratory rate greater than 20 breaths.min1;
temperature greater than 38°C or less than 36°C; heart
rate greater than 90 beats.min1; and white blood cell
count greater than 12,000 mm3, less than 4000 mm3
or greater than 10% bands [6]. We deﬁned qSOFA
scores as systolic blood pressure ≤ 100 mmHg, respira-
tory rate ≥ 22 breaths.min1 and altered mental status
(deﬁned as either a Glasgow Coma Scale score ≤ 13 or
an Alert Voice Pain Unresponsive scale (AVPU) other
than ‘Alert’) [10]. We calculated SOFA and NEWS
scores based on previously published tables [11, 15].
To calculate SOFA scores and determine organ
dysfunction according to the SEPSIS-1 deﬁnition, we
used laboratory values within 24 h of study enrolment,
and if no prior values were available, a median (nor-
mal) value was imputed, as in previous studies [3, 10,
16]. Most patients did not have an arterial blood gas
available at time of observation, so to calculate the res-
piratory component of the SOFA score, we followed
the algorithm developed and validated by Pandhari-
pande et al. [16]. We deﬁned infection-related acute
organ dysfunction according to the SEPSIS-1 criteria
as any of the following present: systolic BP < 90 mmHg
or mean arterial pressure < 65 mmHg or lac-
tate > 2.0 mmol.l1 (after initial ﬂuid challenge), inter-
national normalised ratio > 1.5 or activated partial
thromboplastin time > 60 s, bilirubin > 34 lmol.l1,
urine output < 0.5 ml.kg.h1 for 2 h, creatinine > 177
lmol.l1, platelets < 100 9 109 l1, PaO2/FIO2 ratio
below 250, or as SOFA score two or above according to
the SEPSIS-3 deﬁnition [1, 6]. We recorded the NEWS
score on study entry, and we noted if this was the
worst value in the preceding 24-h period. [10, 15]
Data collectors, working in pairs to ensure data
validity and appropriate clinical knowledge, were
supported by continuous online web chat. This
ensured that senior clinicians identiﬁed through the
Welsh Intensive Care Society Audit and Research
Group and three study coordinators were available
throughout the trial period. We provided key study
information through emails, face-to-face training and
online video tutorials, which included the protocol,
answers to key questions and description of the elec-
tronic case report form (eCRF) on the electronic
tablets. We previously published the details of the digi-
tal data collection platform developed for this study
[8].
We collected data from medical and nursing
records, including baseline characteristics, baseline co-
morbidity and frailty (according to the Dalhousie Clin-
ical Frailty Scale), physiological and laboratory values
and process measures (such as critical care involvement
and completion of sepsis care bundles) [17]. We fol-
lowed up patients until 30 days after study enrolment.
The primary outcome measure was mortality
within 30 days of recruitment. Secondary outcomes
were the presence of organ dysfunction deﬁned by
SOFA score > 2 or the presence of ‘severe sepsis’
according to the SEPSIS-1 deﬁnition [10, 18].
Categorical variables are described as proportions
and were compared using Chi-square or Fisher’s exact
test. We performed comparisons of continuous vari-
ables using one-way ANOVA or Mann–Whitney U-
test as appropriate.
To assess the performances of the SEPSIS-1 and
SEPSIS-3 deﬁnitions to predict the primary end-point,
we calculated diagnostic performances (sensitivity,
speciﬁcity, negative and positive predictive values). We
constructed a receiver operating characteristic (ROC)
curve and calculated the corresponding area under the
ROC curve (AUROC). We plotted Kaplan–Meier sur-
vival curves and compared time-to-event data using
log-rank testing. We estimated the respective hazard
ratios (HRs) for the primary outcome within 30 days
of SEPSIS-1 and SEPSIS-3 deﬁnitions with a Cox pro-
portional hazards model after adjustment for measured
confounders. The model ﬁt was assessed by the 2 log
likelihood statistics and Chi-square test. All statistical
tests were calculated using SPSS 20.0 (SPSS Inc., Chi-
cago, IL, USA). A two-tailed p < 0.05 was considered
statistically signiﬁcant.
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Results
There were 5422 inpatients in the 24-h study period
in the 13 participating hospitals (Fig. 1). Four hun-
dred and thirty-one (7.9%) patients had NEWS ≥ 3
and documented clinical suspicion of infection, and
all were approached for recruitment. Sixty-four
patients (16.8%) were recruited in the ED, and
the others from a variety of ward-based environ-
ments. Baseline characteristics are summarised in
Table 1.
We identiﬁed 212 patients as having sepsis using
the SEPSIS-1 deﬁnition, and 272 patients using the
SEPSIS-3 deﬁnition with SOFA ≥ 2 (Fig. 2); using the
qSOFA, 50 fulﬁlled the deﬁnition criteria (Fig. 2). Out
of the cohort of 380 patients, 44 fulﬁlled neither the
SEPSIS-1 nor the SEPSIS-3 criteria (Fig. 2). The char-
acteristics of these groups and secondary outcomes are
shown in the Supporting Information Table S1. Sepsis-
related organ dysfunction (‘severe sepsis’) was present
in 124 out of 212 patients (58.5%) according to SEP-
SIS-1 criteria. Ninety-nine out of 124 (79.8%) patients
had SOFA ≥ 2 and 24 out of 124 (19.4%) had
qSOFA ≥ 2.
Out of the 272 patients with sepsis using the SEP-
SIS-3 deﬁnition, 183 (67.3%) fulﬁlled ‘severe sepsis’
criteria. Two hundred and thirty-two out of 272
(85.3%) patients had SOFA ≥ 2 using only basic physi-
ological (respiratory, cardiovascular and neurological)
parameters.
SEPSIS-1 and SEPSIS-3 deﬁnitions identiﬁed vari-
ous proportions of 78 out of 380 (20.5%) patients who
died within 30 days (Fig. 3). We found a statistically
signiﬁcant difference in the survival of patients
described by the SEPSIS-1 and SEPSIS-3 deﬁnitions, or
meeting both criteria (Fig. 4).
We report the predictive performances of SEPSIS-
1 and SEPSIS-3 deﬁnitions in Table 2 and Supporting
Information Fig. S1.
After adjustment for age and the presence of heart
failure and using a Cox model, we found that the
SEPSIS-3 deﬁnition was associated with death with HR
(95%CI) 2.7 (1.5–5.6). The previous SEPSIS-1 deﬁni-
tion had a HR of 1.6 (1.03–2.5).
Scoring system discrimination for the primary out-
come was highest for SOFA (AUROC (995%CI) 0.70
(0.63–0.77), p < 0.001), followed by NEWS (0.59
(0.51–0.66), p = 0.02). The positive likelihood ratio
(95%CI) was 1.27 (1.13–1.43) for SOFA, and 1.48
(1.02–2.16) for NEWS. The negative predictive value
for SOFA was 89% (81–94%) and for NEWS 73% (67–
77%). The SIRS (0.55 (0.48–0.62)) and qSOFA score
(0.57 (0.49–0.64)) could not statistically predict out-
come in this patient population (p = 0.21 and 0.07 for
SIRS and qSOFA, respectively). We report the predic-
tive capabilities of qSOFA ≥ 2, severe sepsis criteria
deﬁned by the SEPSIS-1 deﬁnition and NEWS ≥ 6 in
Table 2.
Prognostic performances of SOFA, qSOFA, SIRS
and NEWS to predict acute organ dysfunction are
reported in Supporting Information Table S2 and
Fig. S2. Sequential Organ Failure Assessment was the
best predictive model (AUROC 0.950 (0.930–0.971),
p < 0.001), followed by NEWS (0.694 (0.634–0.754),
p < 0.001), qSOFA (0.668 (0.606–0.730), p < 0.001)
and SIRS (0.580 (0.514–0.647), p = 0.029).
Fifty-nine patients (15.5%) were screened for sep-
sis using the ofﬁcial All Wales sepsis screening tool.
The ‘Sepsis 6’ bundle was completed on 44 occasions
(11.6%), and critical care outreach was involved in 33
Figure 1 Organisational ﬂow chart of the study. Two-
hundred and seven patients gave consent on the day,
66 patient representatives gave assent and 107 patients
were entered following professional assent. Fifty-one
patients (46 patients and 5 patient representatives)
refused participation and no data were collected. ED,
emergency department.
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cases (8.7%). Intravenous antibiotics were administered
either as a mono- or a combination therapy to 220
(57.9%) patients.
Discussion
This is, to our knowledge, the ﬁrst prospective evalua-
tion of the diagnostic and predictive capability of
SEPSIS-1 vs. SEPSIS-3 criteria in the UK. There was
considerable overlap between them, with SEPSIS-3
identifying a larger proportion of patients at risk. How-
ever, of 63 (16.6%) patients, 12 of them falling into the
previous ‘severe sepsis’ category would have been
missed by applying only the new SEPSIS-3 deﬁnitions.
On the other hand, application of SIRS-based criteria
Table 1 Baseline characteristics of the patients in the whole cohort and comparing the survivors with those who died
within 30 days. Values are number (proportion) or median (IQR [range]).
All patients Patients who died Survivors
n = 380 n = 78 n = 302
Sex; men 180 (47%) 46 (59%) 134 (44%)
Age; y 74 (61–83 [18–100]) 77 (72–87 [22–100]) 73 (58–81 [18–96])
Systolic blood
pressure; mmHg
113 (99–136 [74–243]) 113 (101–137 [80–243]) 112 (99–136 [74–220])
Respiratory rate;
breaths.min1
20 (18–22 [13–40]) 20 (18–23 [13–32]) 20 (18–22 [13–40])
Heart rate; beats.min1 94 (80–105 [38–198] 95 (83–108 [47–179]) 93 (80–104 [38–198])
Glasgow Coma Scale < 15 51 (13%) 21 (25%) 30 (10%)
Temperature; Celsius 36.6 (36.1–37.3 [34.2–39.7]) 36.5 (35.9–37.2 [34.3–38.7]) 36.8 (36.1–37.4 [34.4–39.7])
AVPU < Alert 20 (5%) 10 (12%) 10 (3%)
Clinical signs of infection
Cough 176 (46%) 42 (53%) 134 (44%)
Dysuria 39 (10%) 10 (13%) 29 (10%)
Abdominal pain 68 (18%) 17 (22%) 51 (17%)
Headache 20 (5%) 1 (1%) 19 (6%)
Other 162 (55%) 34 (44%) 128 (42%)
Laboratory results
White blood cell
count; cells.ml1
11,250 (8375–15,225 [0–56,000]) 11,700 (8900–17,250 [1300–45,000]) 11,200 (8200–14,625 [0–56,000])
Platelet count; 1000.ml1 269 (187–348 [0–920])* 223 (147–376 [10–876]) 274 (197–347 [0–920])
Creatinine; lmol.l1 76 (61–107 [2–671])* 89 (63–137 [21–671]) 75 (60–99 [2–588])
Bilirubin; lmol.l1 10 (6–16 [0–570])* 14 (7–28 [3–341]) 10 (6–15 [2–570])
Lactate; mmol.l1 1.5 (1.1–2.6 [0.0–14.7])* 1.8 (0.9–3.0 [0–7.4]) 1.5 (1.1–2.45 [0–14.7])
Clinical frailty score 5 (3–6 [1–9]) 6 (5–7 [2–9]) 4 (3–6 [1–9])
SIRS
0 20 (5%) 4 (5%) 16 (5%)
1 116 (31%) 18 (23%) 98 (32%)
2 127 (33%) 28 (36%) 99 (33%)
3 92 (24%) 24 (31%) 68 (22%)
4 25 (7%) 4 (5%) 21 (7%)
qSOFA
0 152 (40%) 27 (34%) 125 (41%)
1 177 (47%) 33 (42%) 144 (48%)
2 43 (11%) 15 (19%) 29 (10%)
3 7 (2%) 3 (4%) 4 (1%)
SOFA 2 (1–4 [1–11]) 4 (2–5 [1–11]) 2 (1–3 [1–10])
SOFA ≥ 2
No 108 (28%) 10 (13%) 98 (32%)
Yes 272 (72%) 67 (86%) 205 (67%)
NEWS 4 (3–6 [3–15]) 5 (3–7 [3–15]) 4 (3–6 [3–12])
NEWS ≥ 6
No 265 (70%) 46 (59%) 219 (73%)
Yes 115 (30%) 32 (41%) 83 (27%)
*Data unavailable in 36.3% (serum bilirubin), 7.9% (serum creatinine), 6.3% (platelet count) and 66.3% (serum lactate) cases.
AVPU, Alert/Verbal response/Response to pain/Unresponsive; SIRS, systemic inﬂammatory response syndrome; qSOFA, quick
Sequential Organ Failure Assessment score; SOFA, Sequential Organ Failure Assessment score; NEWS, National Early Warning Score.
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(SEPSIS-1) did not identify 105 (27.3%) patients, all of
whom had evidence of acute organ dysfunction.
Our results add further to the debate about the
clinical usefulness of the qSOFA score, which was
developed as an easy-to-use prediction tool for identi-
fying patients at risk in the sepsis population [10].
There is ongoing controversy surrounding the utility
and efﬁcacy of qSOFA in the pre-hospital, ED and
general ward setting [19–23]. We found that using
only the qSOFA score, 50 (13.2%) patients would have
been diagnosed with sepsis, missing 116 (30.5%)
patients with organ dysfunction. In contrast to the
results of Seymour et al., qSOFA also failed to predict
outcome at 30 days, and did not offer any predictive
value over the SOFA and NEWS scores for ability to
predict infection-induced acute organ failure in this
patient population [10]. We found a striking discon-
nect between SOFA and qSOFA scores. Although our
sample size is too small to draw ﬁrm conclusions, we
have seen that the biggest discrepancy was between the
respiratory element of SOFA and qSOFA scores (data
not shown). It is possible that the SpO2/FiO2 ratio
used in our study is a much more sensitive parameter
to indicate respiratory compromise, than the high
n = 19n = 31
n = 117
n = 105
n = 64
Figure 2 Patients identiﬁed having sepsis using the
SEPSIS-1 and SEPSIS-3 clinical criteria. SOFA,
Sequential Organ Failure Assessment score; SIRS,
systemic inﬂammatory response syndrome criteria;
qSOFA, quick Sequential Organ Failure Assessment
score; SEPSIS-1 is deﬁned by SIRS ≥ 2. SEPSIS-3 is
deﬁned by SOFA ≥ 2 and/or qSOFA ≥ 2. Forty-four
did not fulﬁl either SEPSIS-1 or SEPSIS-3 criteria.
n = 5n = 12
n = 31
n = 19
n = 10
Figure 3 Distribution of SEPSIS-1 and SEPSIS-3 clini-
cal criteria in patients who died within 30 days
(n = 78). SOFA, Sequential Organ Failure Assess-
ment score; SIRS, systemic inﬂammatory response
syndrome criteria; qSOFA, quick Sequential Organ
Failure Assessment score; SEPSIS-1 is deﬁned by
SIRS ≥ 2. SEPSIS-3 is deﬁned by SOFA ≥ 2 and/or
qSOFA ≥ 2. One patient did not fulﬁl either SEPSIS-1
or SEPSIS-3 criteria.
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Figure 4 Survival difference of patients with different
deﬁnitions of sepsis. Not meeting any sepsis criteria
(black solid line), SEPSIS-1 deﬁnition (yellow dotted
line), SEPSIS-3 deﬁnition (blue dashed line), both SEP-
SIS-1 and SEPSIS-3 deﬁnition (red dashed line with
dots), *p = 0.015.
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respiratory rate in the qSOFA system. Our results war-
rant careful interpretation, as our sample size was
orders of magnitude smaller compared with the origi-
nal qSOFA study [10].
In their large dataset of non-ICU patients, median
(IQR) SOFA was 1 (2), with signiﬁcantly lower hospi-
tal mortality of 3% indicating a population at lower
risk compared with ours. Interestingly, in their ICU
cohort with a mortality of 17%, the AUROC of qSOFA
at 0.66 (95%CI 0.64–0.68) was only slightly better than
we have observed. Similarly, Raith et al. could not con-
ﬁrm the ﬁndings of the original paper in a patient
population where the baseline risk was signiﬁcantly
higher with a hospital mortality of 18.7%, with
AUROC 0.607 (0.603–0.611) [24]. These data suggest
that qSOFA might not be a valuable tool to predict
outcome in populations where the baseline risk of
death is higher than 15%.
Our ﬁndings could support the use of SOFA scores
even in a resource-limited ward setting, although it is
unclear how this might best be integrated into already
established track and trigger systems [10, 19, 22, 25,
26]. Donnelly et al. were able to show in a population-
based study that high admission SOFA was the best
tool predict poor outcome in the hospital and within
one year after discharge, with similar AUROC (0.765)
and HR 2.43 (95%CI 1.84–3.21) to ours [25]. It is clear
from these emerging data that a SIRS-based classiﬁca-
tion of sepsis is inferior to SOFA for delineating
patient cohorts at the highest risk of poor outcome [1,
22, 25]. The exact cut-off for SOFA might need further
recalibration; however, the current threshold of two or
more could be used in the vast majority of patients, by
calculating the SOFA score from physiological parame-
ters readily available at the bed-side.
The high speciﬁcity and positive predictive value
of NEWS ≥ 6 for acute organ dysfunction and adverse
outcome underlines the utility and importance of the
current escalation protocol (‘NEWS Six = Sick’) in our
healthcare system [27]. Similar to our data, NEWS ≥ 7
was found as the best cut-off for predicting poor out-
come in a large retrospective cohort of patients with
sepsis [23]. Recently, a multi-centre Scottish study also
found that NEWS ≥ 6 carried an increased risk of
death and ICU admission in patients admitted to the
ED with sepsis [28].
Sepsis either deﬁned by the SEPSIS-1 or SEPSIS-3
criteria had a high mortality; 22.9% of the patients
died within 30 days, signiﬁcantly higher than the 2.2%
mortality observed in the group which did not fulﬁl
either criteria for the diagnosis of sepsis. This was
almost identical to the 22% 30-day mortality observed
in our previous study, but signiﬁcantly higher than the
6% and 8% mortality observed in the recent studies
involving ED and ward patients [7, 19, 23]. This could
probably be explained by methodological differences
between studies. Churpek et al. used a retrospective
dataset, with wider screening criteria more likely to
capture patients with lower acuity [23]. In fact, only
28% of their 30677 patients met severe sepsis deﬁni-
tion and the mortality of this subset was not reported
[23]. With a focus on the ED, only 20% of patients in
Freund’s study met the SEPSIS-3 deﬁnition and the
mortality rate was not available for this cohort [19]. In
our dataset, mortality was highest when patients met
both SEPSIS-1 and SEPSIS-3 deﬁnitions, highlighting
Table 2 Diagnostic performances of different sepsis deﬁnitions and clinical tools for the prediction of mortality at
30 days.
SEPSIS-1 SEPSIS-3 qSOFA ≥ 2
SEPSIS-1
severe sepsis NEWS ≥ 6
Sensitivity; % (95%CI) 68 (56–78) 86 (76–92) 22 (14–33) 92 (83–97) 41 (30–53)
Specificity; % (95%CI) 47 (41–53) 32 (27–38) 89 (85–92) 24 (19–29) 73 (67–77)
Positive predictive value; % (95%CI) 25 (19–31) 25 (20–30) 34 (22–49) 24 (19–29) 30 (26–35)
Negative predictive value; % (95%CI) 85 (78–90) 90 (82–95) 82 (77–85) 92 (83–97) 70 (65–74)
Positive likelihood ratio (95%CI) 1.28 (1.06–1.54) 1.27 (1.13–1.43) 1.99 (1.17–3.39) 1.21 (1.11–1.33) 1.49 (1.08–2.06)
Negative likelihood ratio (95%CI) 0.68 (0.49–0.95) 0.43 (0.25–0.76) 0.88 (0.78–0.99) 0.32 (0.15–0.71) 0.81 (0.67–0.98)
SEPSIS-1, 1992 deﬁnition of sepsis criteria as deﬁned by Bone et al. [6]; SEPSIS-3, Third International Consensus Deﬁnition of
sepsis criteria [1]; qSOFA, quick Sequential Organ Failure Assessment score; SEPSIS-1 severe sepsis, sepsis with organ dysfunction
as deﬁned by Bone et al. [6]; NEWS, National Early Warning Score.
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the high risk of death when infection causes end-organ
dysfunction [1, 9]. On the other hand, the recent
PROMISE trial in the UK, that recruited patients with
severe sepsis and septic shock according to the SEP-
SIS-1 deﬁnition, reported 24.5% mortality at 28 days
in the control arm, where patient characteristics were
similar to our study [29]. We included all patients
regardless of their ‘do not attempt resuscitation’ status,
or with treatment limited to certain levels, and this
could have affected mortality rates in our study.
Our results highlight the need for a simple, fast
assessment tool to identify patients on the general
wards with sepsis. In the UK, anaesthetists, will see
many of these patients and evaluate them using more
sophisticated clinical tools but enabling the ward staff
to streamline these referrals is crucial to improve pro-
cesses of care.
The strengths of our work include the use of
robust, previously published data collection methodol-
ogy tested over subsequent studies, and the wide par-
ticipation of centres [7, 8]. We prospectively collected
data on patients where the clinical teams suspected
infection, hence we were able to test the real-life utility
of the new sepsis deﬁnition and proposed clinical tools
and compared its performance with the already imple-
mented SEPSIS-1 criteria. Our study has high internal
validity as in our subsequent trials using similar
methodology we recruited similar number of patients
with almost identical outcomes in the same hospitals
[7, 30].
Our study has some limitations. Firstly, our data-
set was a compromise between being an exhaustive list
of possible determinants of sepsis using different deﬁ-
nitions, and being small enough to maintain data col-
lector participation and data reliability. Secondly, we
followed our patients up for only 30 days and did not
collect data on cause of death. Long-term quality of
life survey and healthcare utilisation will be taken for-
ward as part of a longitudinal study. Thirdly, based on
the ﬁndings of others, it is possible that we could also
have missed patients with sepsis who had NEWS
below 3 (e.g. patients with high temperature and white
cell count, but normal respiratory rate and heart rate)
[23, 31]. However, recent data suggest that NEWS ≥ 3
may be the best trigger to screen patients for sepsis in
the ED [32]. Fourthly, laboratory elements of the
SOFA score were missing in a number of patients;
serum bilirubin in 36.3%, serum creatinine in 7.9%
and platelet count in 6.3% of the cases. It is possible
that, due to these omissions, the number of patients
with sepsis according to the SEPSIS-3 criteria is under-
represented in our sample. Similarly, only 33.7% of
patients had their lactate measured, possibly resulting
in misrepresentation of the severe sepsis category.
In conclusion, the SEPSIS-3 deﬁnition identiﬁed
patients with the highest risk if the full SOFA score
was used; however, there was considerable overlap
between the patients identiﬁed by the two deﬁnitions.
SOFA and NEWS were found to be better predictors
of poor outcome than qSOFA or SIRS in our popula-
tion. These ﬁndings will have important implications
for clinicians at the bedside and for organisations try-
ing to improve the quality of sepsis care. For health-
care systems with established track and trigger
mechanisms, the optimal approach to integrating the
new sepsis screening criteria with pre-existing escala-
tion tools has yet to be determined.
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